Changes in blood pressure and systemic vascular resistance do not predict microvascular structure during treatment of mild essential hypertension

Journal of Hypertension

Volumn 30, Issue 4, 2012, Pages 794-801

  Eftekhari, Ashkan ^a,b   Mathiassen, Ole N ^a,b   Buus, Niels H ^a   Gotzsche, Ole ^a   Mulvany, Michael J ^b   Christensen, Kent L ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

blood pressure; coronary flow reserve; essential hypertension; minimum coronary resistance; minimum forearm resistance; systemic vascular resistance

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; BREATHING; CORONARY FLOW RESERVE; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; FOREARM BLOOD FLOW; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; MONOTHERAPY; OBSERVATIONAL STUDY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC VASCULAR RESISTANCE;

EID: 84858705605     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328350e4ff     Document Type: Article

References (54)

1. Beevers G, Lip GY, O'Brien E. ABC of hypertension: the pathophysiology of hypertension. BMJ 2001; 322:912-916. (Pubitemid 32324319)
2. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70:921-961. (Pubitemid 20364819)
3. Mulvany MJ. Small artery remodelling in hypertension: causes, consequences and therapeutic implications. Med Biol Eng Comput 2008; 46:461-467.
4. de Ciuceis C, Porteri E, Rizzoni D, Rizzardi N, Paiardi S, Boari GE, et al. Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens 2007; 20:846-852. (Pubitemid 47176353)
5. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 2007; 25:1021-1026. (Pubitemid 46573121)
6. Rizzoni D, Porteri E, Boari GE, de Ciuceis C, Sleiman I, Muiesan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108:2230-2235. (Pubitemid 37363040)
7. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23:83-91. (Pubitemid 24022048)
8. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
9. Buus NH, Bottcher M, Jorgensen CG, Christensen KL, Thygesen K, Nielsen TT, et al. Myocardial perfusion during long-term angiotensinconverting enzyme inhibition or beta-blockade in patients with essential hypertension. Hypertension 2004; 44:465-470. (Pubitemid 39281497)
10. Mathiassen ON, Buus NH, Larsen ML, Mulvany MJ, Christensen KL. Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment. J Hypertens 2007; 25: 1027-1034. (Pubitemid 46573122)
11. Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
12. Olsen MH, Wachtell K, Meyer C, Hove JD, Palmieri V, Dige-Petersen H, et al. Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy. J Hum Hypertens 2004; 18:445-452. (Pubitemid 38787040)
13. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozakova M, La CG, et al. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 2003; 21:625-631. (Pubitemid 36418976)
14. Rosei EA, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, et al. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995; 13:341-347.
15. Pedrinelli R, Dell'Omo G, Gimelli A, Di Bello V, Talarico L, Corchia A, et al. Myocardial and forearm blood flow reserve in mild-moderate essential hypertensive patients. J Hypertens 1997; 15:667-673. (Pubitemid 27246544)
16. Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihypertensive treatment on small artery remodelling. J Hypertens 2009; 27:1107-1114.
17. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001; 19:921-930. (Pubitemid 32436957)
18. Eftekhari A, Mathiassen ON, Buus NH, Gotzsche O, Mulvany MJ, Christensen KL. Disproportionally impaired microvascular structure in essential hypertension. J Hypertens 2011; 29:896-905.
19. Mulvany MJ. Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol 2011.
20. Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens 2001; 19:1001-1006. (Pubitemid 32493631)
21. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens 2008; 26:1290-1299.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463. (Pubitemid 41821197)
23. Dimitrow PP, Galderisi M, Rigo F. The noninvasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound 2005; 3:18.
24. Rigo F, Murer B, Ossena G, Favaretto E. Transthoracic echocardiographic imaging of coronary arteries: tips, traps, and pitfalls. Cardiovasc Ultrasound 2008; 6:7.
25. Sicari R, Rigo F, Gherardi S, Galderisi M, Cortigiani L, Picano E. The prognostic value of Doppler echocardiographic-derived coronary flow reserve is not affected by concomitant antiischemic therapy at the time of testing. Am Heart J 2008; 156:573-579.
26. Kuriki S, Nasu M, Fukami KK, Hiramori K. noninvasive measurement of left coronary blood flow reserve by transthoracic Doppler echocardiography: comparison with Doppler guidewire ultrasonography. Echocardiography 1999; 16:547-557. (Pubitemid 29413548)
27. Kiviniemi TO, Toikka JO, Koskenvuo JW, Saraste A, Saraste M, Parkka JP, et al. Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography. Ultrasound Med Biol 2007; 33:362-370. (Pubitemid 46275181)
28. Clemensen P, Christensen P, Norsk P, Gronlund J. A modified photoand magnetoacoustic multigas analyzer applied in gas exchange measurements. J Appl Physiol 1994; 76:2832-2839. (Pubitemid 24184815)
29. Damgaard M, Norsk P. Effects of ventilation on cardiac output determined by inert gas rebreathing. Clin Physiol Funct Imaging 2005; 25:142-147. (Pubitemid 40778899)
30. Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P, et al. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1294-R1301.
31. Mathiassen ON, Buus NH, Olsen HW, Larsen ML, Mulvany MJ, Christensen KL. Forearm plethysmography in the assessment of vascular tone and resistance vasculature design: new methodological insights. Acta Physiol (Oxf) 2006; 188:91-101. (Pubitemid 44337806)
32. Bakker EN, Buus CL, VanBavel E, Mulvany MJ. Activation of resistance arteries with endothelin-1: from vasoconstriction to functional adaptation and remodeling. J Vasc Res 2004; 41:174-182. (Pubitemid 38478874)
33. Schiffrin EL, Pu Q, Park JB. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens 2002; 15:105-110. (Pubitemid 34161083)
34. Aalkjaer C, Heagerty AM, Mulvany MJ. In vitro characteristics of vessels from patients with essential hypertension. J Clin Hypertens 1987; 3:317-322. (Pubitemid 18048987)
35. Rizzoni D, de Ciuceis C, Porteri E, Paiardi S, Boari GE, Mortini P, et al. Altered structure of small cerebral arteries in patients with essential hypertension. J Hypertens 2009; 27:838-845.
36. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88:993-1003. (Pubitemid 23264015)
37. Short DS. Arteries of intestinal wall in systemic hypertension. Lancet 1958; 2:1261-1263.
38. Ritt M, Harazny JM, Ott C, Schlaich MP, Schneider MP, Michelson G, et al. Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens 2008; 26:1427-1434.
39. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51:55-61. (Pubitemid 350307104)
40. Dimitrow PP, Krzanowski M. Coronary flow reserve assessment. Eur Heart J 2005; 26:849-850.
41. Hoffman JI. Maximal coronary flow and the concept of coronary vascular reserve. Circulation 1984; 70:153-159. (Pubitemid 14053035)
42. Rigo F. Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool. Cardiovasc Ultrasound 2005; 3:8.
43. Strauer BE, Schwartzkopff B, Kelm M. Assessing the coronary circulation in hypertension. J Hypertens 1998; 16:1221-1233. (Pubitemid 28408403)
44. Prinzmetal M, Wilson C. The nature of the peripheral resistance in arterial hypertension with special reference to the vasomotor system. J Clin Invest 1936; 15:63-83.
45. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62:347-504.
46. Veerman DP, Imholz BP, Wieling W, Wesseling KH, van Montfrans GA. Circadian profile of systemic hemodynamics. Hypertension 1995; 26:55-59.
47. Mori H. Circadian variation of haemodynamics in patients with essential hypertension. J Hum Hypertens 1990; 4:384-389. (Pubitemid 20260454)
48. Christensen P, Clemensen P, Andersen PK, Henneberg SW. Thermodilution versus inert gas rebreathing for estimation of effective pulmonary blood flow. Crit Care Med 2000; 28:51-56. (Pubitemid 30091028)
49. Peyton PJ, Thompson B. Agreement of an inert gas rebreathing device with thermodilution and the direct oxygen Fick method in measurement of pulmonary blood flow. J Clin Monit Comput 2004; 18: 373-378. (Pubitemid 40867423)
50. Segal SS. Cell-to-cell communication coordinates blood flow control. Hypertension 1994; 23:1113-1120. (Pubitemid 24180876)
51. Segal SS. Regulation of blood flow in the microcirculation. Microcirculation 2005; 12:33-45. (Pubitemid 40450616)
52. Patterson GC, Whelan RF. Reactive hyperaemia in the human forearm. Clin Sci (Lond) 1955; 14:197-211.
53. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82:1595-1606. (Pubitemid 20367962)
54. O'Rourke MF. How stiffening of the aorta and elastic arteries leads to compromised coronary flow. Heart 2008; 94:690-691. (Pubitemid 351744683)